Articles

Keeping in touch with all of you

As we move into summer and I've settled more comfortably into the chief editor's chair, it's time to step up our social media activity, and to let you know about our new Facebook page
Written byJeffrey Bouley
| 2 min read

I’m not a big talker. Part of it is just my natural ability to stumble over words at random intervals and the fact that, as my wife keeps reminding me, I just speak way too quietly. Which is funny; sure, I was a shy kid and teenager overall, but I wasn’t antisocial or reserved. I had plenty of friends and sometimes even made connections with popular students, but I wasn’t the kind of person who liked to be the center of attention in a crowd, nor was I any good at working up the courage to ask ladies out on dates.

To continue reading this article, subscribe for FREE toDrug Discovery News Logo

Subscribe today to keep up to date with the latest advancements and discoveries in drug development achieved by scientists in pharma, biotech, non-profit, academic, clinical, and government labs.

Add Drug Discovery News as a preferred source on Google

Add Drug Discovery News as a preferred Google source to see more of our trusted coverage.

About the Author

Here are some related topics that may interest you:

Subscribe to Newsletter

Subscribe to our eNewsletters

Stay connected with all of the latest from Drug Discovery News.

Subscribe

Sponsored

3D illustration of a single cell surrounded by small molecular particles in a red biological environment.
Measuring mRNA and protein together at single cell resolution can uncover tumor-specific signaling activity and immune features.
Illustration of an antibody intertwined with a DNA double helix.
Discover how CRISPR and single-cell RNA sequencing can connect disease-associated variants to regulatory elements, genes, and pathways.
Digital illustration of the human digestive system highlighting the liver, stomach, and intestines.
Explore how human gut-liver models can improve the translation of preclinical findings into clinical pharmacokinetic predictions.